...
Diversa Corporation is a leader in applying proprietary genomic technologies for the rapid discovery and optimization of novel products from genes and gene pathways. Diversa is ......) focused on near-term commercialization of products for the industrial and agricultural markets, ...
...
Pharmacodynamic measurements of tubulin stabilization in peripheral blood cells demonstrated dose-dependent biological activity of KOS-862. As the dose of 100 mg/m2 ...
...
is engaged in the discovery, development and commercialization of products that harness the human immune system to prevent ...... Current collaborations encompass the development of an oral human rotavirus vaccine, vaccines to combat threats of biological warfare, and vaccines addressed to human food ...
... Visibility for quarterly comparisons is made difficult by the fact that several of the Company's largest customers purchase hyaluronan products on an irregular basis. Therefore, sequential ...
